[Acute pyelonephritis associated with intestinal dysbacteriosis: incidence and enhancement of efficiency of treatment].
A study was made on the incidence rate of acute pyelonephritis associated with intestinal dysbacteriosis in urological patients (n = 68). Prehospitalization and precombined-treatment duration of the illness came up to one to four days. It has been ascertained as a result of the conducted study that under present ecological conditions, acute pyelonephritis runs its course in the presence in patients of dysbacteriosis of the intestines even before the start of treatment in an urological clinic setting. Antibacterial treatment of patients with acute pyelonephritis without simultaneous action on the pathogenic intestinal microflora and normalization of colonizing normoflora was found to produce profound aggravation of dysbacteriosis and to result in the development of candidasis. Extermination with the aid of the intestinal antibiotic intetrix of the pathogenic microflora in the intestines together with achieving of normalization of intestinal normoflora by way of the enteral intake by patients with acute pyelonephritis of eubiotics permit the marked improvement to be achieved in results of combined treatment thereof.
Ukhal'
E M
EM
Ukhal'
M I
MI
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001644:Bifidobacterium; D004338:Drug Combinations; D006801:Humans; D015994:Incidence; D007410:Intestinal Diseases / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*; D007778:Lactobacillus; D008875:Middle Aged; D015125:Oxyquinoline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019936:Probiotics / Q000627:therapeutic use; D011704:Pyelonephritis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D015125:Oxyquinoline; C037666:intetrix